← Browse by Condition
Medical Condition
acute leukemia of ambiguous lineage
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2
NCT06575296 Phase 1
Recruiting
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Enrollment
27 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Enrollment
153 pts
Location
United States, Puert...
Sponsor
National Cancer Institute (NCI...
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center